T-Cell Non-Hodgkin Lymphomas: Spectrum of Disease and the Role of Imaging in the Management of Common Subtypes

被引：13

作者：

Park, Hye Sun ^{[1
,2
]}

McIntosh, Lacey ^{[3
,4
]}

Braschi-Amirfarzan, Marta ^{[3
,4
]}

Shinagare, Atul B. ^{[3
,4
]}

Krajewski, Katherine M. ^{[3
,4
]}

机构：

[1] Univ Ulsan, Coll Med, Dept Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[2] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, 88 Olymp Ro 43 Gil, Seoul 05505, South Korea

[3] Harvard Med Sch, Dana Farber Canc Inst, Dept Imaging, Boston, MA 02215 USA

[4] Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA

来源：

KOREAN JOURNAL OF RADIOLOGY | 2017年 / 18卷 / 01期

关键词：

T-cell lymphoma; Non-Hodgkin lymphoma; CT; MRI; PET-CT; NATURAL KILLER/T-CELL; LYMPHOBLASTIC LYMPHOMA; MYCOSIS-FUNGOIDES; PROGNOSTIC-FACTORS; UNITED-STATES; F-18-FDG PET/CT; SEZARY-SYNDROME; TRANSFORMATION; FEATURES; TRANSPLANTATION;

D O I：

10.3348/kjr.2017.18.1.71

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

T-cell non-Hodgkin Lymphomas (NHLs) are biologically diverse, uncommon malignancies characterized by a spectrum of imaging findings according to subtype. The purpose of this review is to describe the common subtypes of T-cell NHL, highlight important differences between cutaneous, various peripheral and precursor subtypes, and summarize imaging features and the role of imaging in the management of this diverse set of diseases.

引用

页码：71 / 83

页数：13

共 50 条

[21] LYMPHOBLASTIC T-CELL NON-HODGKIN LYMPHOMA
Robbens, C.
Vanwyck, R.
JBR-BTR, 2008, 91 (03): : 110 - 111
[22] Mucosal-Associated Invariant T Cells in T-Cell Non-Hodgkin Lymphomas: A Case Series
Torre, Pietro
Brescia, Annalisa
Giurato, Giorgio
D'Auria, Raffaella
Rizzo, Francesca
Motta, Benedetta Maria
Giudice, Valentina
Selleri, Carmine
Zeppa, Pio
Caputo, Alessandro
Casolaro, Vincenzo
Persico, Marcello
CANCERS, 2022, 14 (12)
[23] Current Immunotherapeutic Approaches in T Cell Non-Hodgkin Lymphomas
Poggio, Teresa
Duyster, Justus
Illert, Anna L.
CANCERS, 2018, 10 (09)
[24] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
Anagha Deshpande
William Rule
Allison Rosenthal
Current Treatment Options in Oncology, 2022, 23 : 89 - 98
[25] Aberrant expression of T-cell antigens on B-cell non-Hodgkin's lymphomas.
Kaleem, Z
Kraus, MD
White, G
Zutter, MM
BLOOD, 1997, 90 (10) : 3911 - 3911
[26] Radiation and Chimeric Antigen Receptor T-cell Therapy in B-cell Non-Hodgkin Lymphomas
Deshpande, Anagha
Rule, William
Rosenthal, Allison
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2022, 23 (01) : 89 - 98
[27] Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas
Lee, Je-Jung
Kim, Dong Hwan
Lee, Nan Young
Sohn, Sang Kyun
Kim, Jong Gwang
Kim, Hyeoung-Joon
Do, Young Rok
Park, Yeon Hee
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 137 (04) : 329 - 336
[28] Potentials, challenges and future of chimeric antigen receptor T-cell therapy in non-Hodgkin lymphomas
El-Galaly, Tarec Christoffer
Cheah, Chan Yoon
Kristensen, Daniel
Hutchison, Andrew
Hay, Kevin
Callreus, Torbjorn
Villa, Diego
ACTA ONCOLOGICA, 2020, 59 (07) : 766 - 774
[29] Role of surveillance imaging in the management of peripheral T-cell lymphomas.
Tang, Tiffany Pool Ling
Chen, Zhengming
Praditsuktavorn, Pannee
Khoo, Lay Poh
Ruan, Jia
Lim, Soon Thye
Tan, Daryl C. L.
Diong, Colin
Lee, Yuh Shan
Tee, Goh Yeow
Hwang, William
Tao, Miriam
Hui, Richard Hong
Tay, Quek Kevin
Farid, Mohamad
Furman, Richard R.
Leonard, John
Martin, Peter
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[30] HODGKIN DISEASE, THE NON-HODGKIN LYMPHOMAS, AND THE LEUKEMIAS IN THE RETROPERITONEUM
CASTELLINO, RA
MARGLIN, S
BLANK, N
SEMINARS IN ROENTGENOLOGY, 1980, 15 (04) : 288 - 301

← 1 2 3 4 5 →